Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof
US9884847B2 · kind B2 · utility
0Cited by
2References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2015 |
| Grant date | Feb 6, 2018 |
| Priority date | — |
| Expiry date | Jul 24, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the formulas (I) and (II):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of Retinoic Acid Receptor-Related Orphan Receptor regulated diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.